Patents by Inventor Lee A. Bulla, Jr.

Lee A. Bulla, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9566292
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: February 14, 2017
    Assignee: Creation One Formulators, LLC
    Inventors: Lee A. Bulla, Jr., Jeffrey Marcus Clark, Natalya Griko, Jian Sun
  • Publication number: 20150342980
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Application
    Filed: June 8, 2015
    Publication date: December 3, 2015
    Applicant: CREATION ONE FORMULATORS, LLC
    Inventors: Lee A. BULLA, JR., Natalya Griko, Jian Sun
  • Patent number: 9051360
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: June 9, 2015
    Assignee: Creation One Formulators, LLC
    Inventors: Lee A. Bulla, Jr., Natalya Griko, Jian Sun, Ralph Clark
  • Publication number: 20130004538
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Application
    Filed: July 9, 2012
    Publication date: January 3, 2013
    Inventors: Lee A. Bulla, JR., Jeffrey Marcus Clark, Natalya Griko, Jian Sun, Ralph Clark
  • Patent number: 8241844
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: August 14, 2012
    Inventors: Lee A. Bulla, Jr., Jeffrey Marcus Clark, Ralph Clark, legal representative, Natalya Griko, Jian Sun
  • Publication number: 20100119556
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Application
    Filed: October 2, 2009
    Publication date: May 13, 2010
    Inventors: Lee A. Bulla, Jr., Jeffrey Marcus Clark, Ralph Clark, Natalya Griko, Jian Sun
  • Publication number: 20100006438
    Abstract: An efficient system for desalinization of water is described wherein multiple stages of deionization result in drinking water quality and provision is made for recycling wastewater through the system.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 14, 2010
    Applicant: Biological Targets, Inc.
    Inventors: Peter P. ANTICH, Lee A. BULLA, JR.
  • Patent number: 7625743
    Abstract: The cDNA that encodes a glycoprotein receptor from the tobacco hornworm which binds a Bacillus thuringiensis toxin has been obtained and sequenced. The availability of this cDNA permits the retrieval of DNAs encoding homologous receptors in other insects and organisms as well as the design of assays for the cytotoxicity and binding affinity of potential pesticides and the development of methods to manipulate natural and/or introduced homologous receptors and, thus, to destroy target cells, tissues and/or organisms.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: December 1, 2009
    Assignee: The University of Wyoming
    Inventor: Lee A. Bulla, Jr.
  • Publication number: 20090198479
    Abstract: A web-based computational system and method for high-throughput gene mining and target identification and validation based on conserved functional blocks automates the generation of conserved regions of high sequence similarity using algorithms and optimizes probe design for fragment amplification from homologous genomes.
    Type: Application
    Filed: July 25, 2008
    Publication date: August 6, 2009
    Inventors: Lee A. BULLA, JR., Jian Sun
  • Publication number: 20090098051
    Abstract: A new Bt Cry toxin, Cry1M is able to exert insecticidal effects on insects and/or nematodes in general, and in addition, on insects that have acquired resistance to alternative Cry proteins.
    Type: Application
    Filed: July 11, 2008
    Publication date: April 16, 2009
    Inventors: Mohamed A. IBRAHIM, Lee A. BULLA, JR.
  • Patent number: 7349811
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: March 25, 2008
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6928368
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: August 9, 2005
    Assignee: The Board Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6797490
    Abstract: A composition and method for killing fire ants is disclosed that includes the purified and activated Cry toxin from a novel strain of Bacillus thuringiensis, wherein the water soluble, partially purified, activated toxin is provided along with an attractant to kill the imported fire ant using a biodegradable, environmentally sound glycoprotein without a need for toxic chemicals.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: September 28, 2004
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6759230
    Abstract: A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars migrating at the same rate as glucose and fucose, and wherein the ratio of galactose:fucose:glucose:mannose is about 1:2:3:6. The microbe and the exopolysaccharide have uses as a biofilm in geologic applications and have several consumer uses as food and drug polymers and use as a plasma extender.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: July 6, 2004
    Assignee: The Board of Regents, The University of Texas
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6691783
    Abstract: A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars migrating at the same rate as glucose and fucose, and wherein the ratio of galactose:fucose:glucose:mannose is about 1:2:3:6. The microbe and the exopolysaccharide have uses as a biofilm in geologic applications and have several consumer uses as food and drug polymers and use as a plasma extender.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: February 17, 2004
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., John P. Turner
  • Patent number: 6660497
    Abstract: A cDNA encoding a 200 kD receptor, BT-R2, from the pink boll worm, Pectinophora gossypiella, that binds specifically to a Bacillus thuringiensis toxin has been cloned, sequenced and characterized. The minimum toxin binding fragment has been identified. The BT-R2 cDNA permits the analysis of receptors in pink boll worm and other insects that affect crop growth and development, as well as, design assays for the cytotoxicity and binding affinity of potential pesticides. The clone and other methods described herein, permit the manipulation of natural and/or introduced homologous receptors and, thus, to specifically destroy organisms, tissues and/or cells of the target host.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: December 9, 2003
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6551800
    Abstract: A nucleic acid derived from Bacillus thuringiensis contains a nucleotide sequence that encodes a polypeptide demonstrated to be toxic to fire ants.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: April 22, 2003
    Assignee: The Board of Regents, The University Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6232439
    Abstract: A broad spectrum Bacillus strain is provided which displays activity against at least two orders of insects. Novel proteins active against corn rootworm and nematodes and methods of isolation are additionally provided. Also provided is a purified crystal protein complex isolated from a Bacillus strain that demonstrates insecticidal properties. In addition, the nucleotide and amino acid sequence of the Cry1I gene isolated from this strain is provided.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: May 15, 2001
    Assignees: University of Wyoming, Agricultrual Genetic Engineering Research Institute
    Inventors: Yehia A. Osman, Magdy A. Madkour, Lee A. Bulla, Jr.
  • Patent number: 6210953
    Abstract: A broad spectrum Bacillus thuringiensis strain, BtC-18, is provided which displays pesticidal activity against nematodes and against insects from the orders Lepidoptera, Diptera and Coleoptera.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: April 3, 2001
    Assignees: University of Wyoming, Agricultural Genetic Engineering Research Institute
    Inventors: Yehia A. Osman, Magdy A. Madkour, Lee A. Bulla, Jr.
  • Patent number: 5986177
    Abstract: A broad spectrum Bacillus strain is provided which displays activity against at least two orders of insects. Novel proteins active against corn rootworm and nematodes and methods of isolation are additionally provided. Also provided is a purified crystal protein complex isolated from a Bacillus strain that demonstrates insecticidal properties. In addition, the nucleotide and amino acid sequence of the Cry1I gene isolated from this strain is provided.
    Type: Grant
    Filed: January 6, 1998
    Date of Patent: November 16, 1999
    Assignees: Agricultural Genetic Engineering Research Institute, University of Wyoming
    Inventors: Yehia A. Osman, Magdy A. Madkour, Lee A. Bulla, Jr.